Rise in Unwanted Pregnancies to Spur Contraceptives Market, Poised to Register Downturn due to COVID-19 Pandemic

Demand for contraceptives to register a robust 6.4% CAGR during the forecast period (2020-2025). The global contraceptives market shall surpass a valuation of US$ 37,242.7 Mn by the end of 2025.

The recent study by Fact.MR on global contraceptives market offers a 5-year forecast between 2020 and 2025. The study analyzes crucial trends that are currently determining the growth of the global contraceptives market.

The contraception encompasses the use of drugs (oral pills, injectable contraceptives, and topical contraceptives) and devices (condoms, intrauterine device [IUD], diaphragms, sponges, patches, implants, vaginal rings, and others). The growth in focus towards the need of family planning and preventing unintended pregnancy fuels the market growth.

Expanding operations in future? To get the perfect launch ask for a sample report at https://www.factmr.com/connectus/sample?flag=S&rep_id=4719

Product Research & Development Key Growth Levers of Companies

• Major market players such as Allergen, plc, Pfizer, Inc, Teva Pharmaceutical Industries Ltd., Bayer AG and Janssen Pharmaceutical Company account for half of the total market share.
• The companies primarily concentrate on product launches in order to broaden their market footprint.
• Pfizer Inc’s Sayana Press, for instance, is the first injectable contraceptive for women available in the U.K. The company is also in the process of conducting a study evaluating levonorgestrel and ethinyl estradiol as potential oral contraceptives.
• Merck & Co, Inc., offers contraceptive care in the form of combined oral pills, vaginal rings, intrauterine devices and sub-dermal implants. Popular products include Cyclessa, Desogen, NuvaRing, Implanon and Nexplanon.
• Another important player, Cipla, manufactures oral contraceptives named Crisanta. The medicine contains Drospirenone which prevents the fertilization of the egg with the sperm. It also induces hormonal changes contributing to the prevention of pregnancy.

Global Contraceptives Market Segmentation

Fact.MR has studied the global contraceptives market with detailed segmentation on the basis of product type, distribution channel and key regions.

Product Type

Contraceptive drugs (hormonal):

Oral Contraceptives:

• Combined Contraceptives
• Mini pills
• Contraceptive Injectable
• Topical Contraceptive Patch

Contraceptive Devices:

Male Contraceptive Devices

Female Contraceptive Devices:

• Female Condoms
• Contraceptive Diaphragms
• Contraceptive Sponges
• Contraceptive Vaginal Rings
• Intrauterine Devices
• Sub-dermal Contraceptive Implants
• Non-surgical Permanent Contraception Devices

Distribution Channel

• Hospital Pharmacy:
• Public
• Private
• Independent Pharmacy
• Online Platform
• Clinics
• Others

Need More information about Report Methodology? Click here https://www.factmr.com/connectus/sample?flag=RM&rep_id=4719

The Center for Medicaid and CHIP Services (CMCS) established a Maternal and Infant Health Initiative for the Medicaid and Children’s Health Insurance Program (CHIP) to promote the use of effective methods of contraception. Such government initiatives to improve family planning and reproductive health has significantly increased awareness and use of contraceptive in the U.S.

COVID-19 Market Insights:

The Covid-19 pandemic has significantly impacted the U.S. healthcare sector. The contraceptives market is majorly dependent on physician-prescribed and physician-administered products. Due to restrictions on visiting physician offices without an emergency, the demand for contraceptive products was low during the first few months of the pandemic. Telehealth services and virtual consultations were recommended for contraceptive screening and counseling.

• North America is anticipated to dominate the contraceptives market, in the wake of growing prevalence of unintended pregnancies, rising demand for reversible contraceptives and public sector initiatives to provide funding for family planning and contraception.
• The region is expected to surpass a valuation of US$ 12,987.4 by 2025. Projected CAGR for the same is pegged at 6.6% during the forecast period.
• The contraceptives market in the Asia-Pacific is projected to surpass a value of US$ 7,925.7 by the end of 2025, expanding at a CAGR of 6.8%.

The study offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales in global contraceptives market across the globe.

A comprehensive estimate on global contraceptive market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of global contraceptives market during the forecast period. Price point comparison by region with global average price is also considered in the study.

To get all-in insights on the regional landscape of the Contraceptive Market, buy now:- https://www.factmr.com/checkout/4719

Frequently Asked Questions About This Report

1. How big is the U.S. contraceptive market?

The U.S. contraceptive market size was estimated at USD 7.1 billion in 2019 and is expected to reach USD 7.4 billion in 2020.

1. What is the U.S. contraceptive market growth?

The U.S. contraceptive market is expected to grow at a compound annual growth rate of 4.35% from 2020 to 2027 to reach USD 9.9 billion by 2027.

1. Which segment accounted for the largest U.S. contraceptive market share?

Pills dominated the U.S. contraceptive market with a share of around 41% in 2019. This is attributable to a large number of products introduced by several market players, a high success rate, and convenience in using oral pills for contraception.

1. Who are the key players in the U.S. contraceptive market?

Some key players operating in the U.S. contraceptive market include Merck & Co. Inc.; Bayer AG; Allergan; Afaxys, Inc.; Mayer Laboratories, Inc.; Teva Pharmaceutical Industries Ltd.; Agile Therapeutics; TherapeuticsMD Inc.; Reckitt Benckiser Plc.; Pfizer, Inc.; Cooper Surgical; Church & Dwight Co., Inc.; and Mithra Pharmaceuticals.

1. What are the factors driving the U.S. contraceptive market?

Key factors that are driving the U.S. contraceptive market growth include increasing awareness regarding the importance of sexual and reproductive health among women in the age group of 15 to 49 years.

Have a Look at Related Research Insights:

Interventional ENT Devices Market Forecast, Trend Analysis & Competition Tracking - Global Review 2021 to 2031 – Read more at https://www.factmr.com/report/978/interventional-ent-devices-market

Allergic Rhinitis Treatment Device Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028 – Read more at https://www.factmr.com/report/2272/allergic-rhinitis-treatment-device-market

Oral & Topical Anaesthetics Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028 – Read more at https://www.factmr.com/report/2279/oral-topical-anaesthetics-market

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates